Delivery Order SPE2DB22D3010-SPE2DB24FP3JG

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $1,477.14 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of WIXELA 500-50 INHUB 60S pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,013.16 fixed-price contract is for the supply of WIXELA 250-50 INHUB 60S, a prescription drug product. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of WIXELA 250-50 INHUB 60S, a prescription pharmaceutical product. The contract has a firm fixed price of $3,742.92 and a completion date of September 26, 2024. It is not designated as a set-aside contract. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,071.60, is for the delivery of WIXELA 100-50 INHUB 60S, a pharmaceutical product. The contract has a firm-fixed price and an ultimate completion date of September 20, 2023. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of WIXELA 250-50 INHUB 60S, a pharmaceutical product. The contract has a ceiling value of $1,128.66 and is a firm fixed price contract type. It was awarded on April 1, 2025 with an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp has...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of WIXELA 500-50 INHUB 60S pharmaceutical products. The award has a ceiling value of $1,626.80 and a completion date of April 10, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,142.21 to Amerisourcebergen Drug Corp, a subsidiary of the for-profit company Amerisourcebergen Corporation. The contract is for the delivery of WIXELA 250-50 INHUB 60S pharmaceutical products to support military treatment programs and facilities. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,283.18, is a delivery order for the supply of WIXELA 500-50 INHUB 60S medical devices. The contract has a completion date of June 5, 2024 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of WIXELA 250-50 INHUB 60S medical supplies. The contract, valued at $2,209.59, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a federal agency that provides medical products and services to the U.S. military and other government organizations. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,475.53, is a delivery order for the WIXELA 250-50 INHUB 60S pharmaceutical product. The contract has an ultimate completion date of January 29, 2025 and uses a firm fixed-price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB24FP3JG
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of WIXELA 250-50 INHUB 60S, a pharmaceutical product. The contract has a firm fixed price of $2,013.63 and an ultimate completion date of September 25, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/24/24, 9:35 AM